U.S. President Donald Trump delivers a speech during a visit to the Fujifilm Diosynth Biotechnologies’ Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. Carlos Barria | Reuters The hunt is on for a vaccine for Covid-19,… Read More »
What your doctor is reading on Medscape.com: By Marcia Frellick July 31, 2020 — Physicians are the most likely group of healthcare professionals to get a COVID-19 vaccine when one is available, according to a new Medscape poll. More than 7000 healthcare professionals, including clinicians, medical students, and administrators, responded to the poll. US physicians who responded… Read More »
A view of Moderna headquarters on May 08, 2020 in Cambridge, Massachusetts. Moderna was given FDA approval to continue to phase 2 of Coronavirus (COVID-19) vaccine trials with 600 participants. (Photo by Maddie Meyer/Getty Images) Moderna Inc., a biotech company that develops pharmaceuticals, received $ 472 million award from the federal Biomedical Advanced Research and… Read More »
A Acellular vaccine: Listen media icon[MP3]A vaccine containing partial cellular material as opposed to complete cells. Acquired Immune Deficiency Syndrome (AIDS): A medical condition where the immune system cannot function properly and protect the body from disease. As a result, the body cannot defend itself against infections (like pneumonia). AIDS is caused by the Human… Read More »
PhotobyTawat/Shutterstock Sheena Cruickshank, University of Manchester SARS-CoV-2 – the virus that causes COVID-19 – belongs to the family of betacoronaviruses that cause everything from the common cold to Mers (which kills about one in three people infected). Despite causing a wide range of symptoms, these viruses all share similarities. If they’re similar enough, could one… Read More »
As wealthy countries race to secure supplies of potential COVID-19 vaccines, the World Health Organization (WHO) unveiled (PDF) an ambitious effort with global partners to provide billions of doses worldwide. Under an $ 18 billion program, the WHO—plus global groups Gavi, the Vaccine Alliance and the Coalition for Epidemic Preparedness Innovations (CEPI)—aim to speed the… Read More »